Compliant Technologies LLC Version 1.2
(859) 447-0576 Last updated:
P.O. Box 24714, Lexington, KY 40524 Page 2of 24
1CONTENTS
2 Safety and Terms ...................................................................................................................................4
2.1 Safety .............................................................................................................................................4
2.2 Terms .............................................................................................................................................4
3 General Overview, Specifications, and Components ............................................................................6
3.1 Overview........................................................................................................................................6
3.2 Specifications.................................................................................................................................6
3.3 Training Model (CT-F2T) ................................................................................................................7
3.4 Component Identification..............................................................................................................7
4 Pre-Operational Checks .........................................................................................................................8
5 G.L.O.V.E. Use and Operation................................................................................................................9
5.1 Charging.........................................................................................................................................9
5.1.1 Generation 3 and 4 devices ...................................................................................................9
5.2 Replacing Micro-Processor..........................................................................................................10
5.2.1 GEN 3, 4 Devices ..................................................................................................................10
5.3 Digital Event Record Retrieval .....................................................................................................11
5.4 Powering On/Off..........................................................................................................................12
5.5 Activating on Subject’s Body .......................................................................................................12
5.6 Tap Test (Optional) ......................................................................................................................12
6 Medical, Physiological Effects and ExDS..............................................................................................13
6.1 Medical Considerations ...............................................................................................................13
6.2 Physiological Considerations .......................................................................................................14
6.3 Agitated Chaotic Event (ACE) previously known as Excited Delirium Syndrom (ExDS) and
Suicidal Considerations............................................................................................................................14
7 Tactical Considerations for Use of Force .............................................................................................15
8 Suggested ROE and Post-Incident Actions...........................................................................................17
8.1 Suggested ROE (Rules of Engagement) Levels.............................................................................17
8.1.1 Level 1..................................................................................................................................17
8.1.2 Level 2..................................................................................................................................18
8.1.3 Level 3..................................................................................................................................19
9 Post-Incident........................................................................................................................................19
9.1.1 CD3 Anonymous After-Action Report..................................................................................19